Although our analysis included a limited number of cases, evaluation of TILs among diverse tumor microenvironment components, and molecular alterations that affect the response to cetuximab, the present study may provide several clues for understanding the role of GRP94 expression in CRC pathogenesis. This evidence concerns the gene HSP90B1 and colorectal carcinoma.